Author: ZENTALIS PHARMACEUTICALS

Posted Date:

April 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ZENTALIS PHARMACEUTICALS

April 1, 2026
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026

ZENTALIS PHARMACEUTICALS

March 17, 2026
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

ZENTALIS PHARMACEUTICALS

February 18, 2026
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference

ZENTALIS PHARMACEUTICALS

February 3, 2026